| The “All of Us” Research Program All of Us Research Program Investigators New England Journal of Medicine 381 (7), 668-676, 2019 | 970 | 2019 |
| Construct validation of the dietary inflammatory index among postmenopausal women FK Tabung, SE Steck, J Zhang, Y Ma, AD Liese, I Agalliu, M Hingle, L Hou, ... Annals of epidemiology 25 (6), 398-405, 2015 | 374 | 2015 |
| Regulation of cell proliferation, apoptosis, and carcinogenesis by activin YG Chen, HM Lui, SL Lin, JM Lee, SY Ying Experimental Biology and Medicine 227 (2), 75-87, 2002 | 342 | 2002 |
| Genome-wide promoter analysis uncovers portions of the cancer methylome MO Hoque, MS Kim, KL Ostrow, J Liu, GBA Wisman, HL Park, ML Poeta, ... Cancer research 68 (8), 2661-2670, 2008 | 202 | 2008 |
| Differential recognition of response elements determines target gene specificity for p53 and p63 M Osada, HL Park, Y Nagakawa, K Yamashita, A Fomenkov, MS Kim, ... Molecular and Cellular Biology 25 (14), 6077-6089, 2005 | 188 | 2005 |
| Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers M Brait, S Ling, JK Nagpal, X Chang, HL Park, J Lee, J Okamura, ... Public Library of Science 7 (9), e44951, 2012 | 143 | 2012 |
| PGP9. 5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma DL Mandelker, K Yamashita, Y Tokumaru, K Mimori, DL Howard, ... Cancer Research 65 (11), 4963-4968, 2005 | 142 | 2005 |
| Effects of a dietary intervention and weight change on vasomotor symptoms in the Women’s Health Initiative CH Kroenke, BJ Caan, ML Stefanick, G Anderson, R Brzyski, KC Johnson, ... Menopause (New York, NY) 19 (9), 980, 2012 | 132 | 2012 |
| Increased plasma DNA integrity index in head and neck cancer patients WW Jiang, M Zahurak, D Goldenberg, Y Milman, HL Park, WH Westra, ... International journal of cancer 119 (11), 2673-2676, 2006 | 128 | 2006 |
| Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer MS Kim, J Louwagie, B Carvalho, JS Terhaar sive Droste, HL Park, ... PLoS One 4 (8), e6555, 2009 | 120 | 2009 |
| N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer MS Kim, K Yamashita, JH Baek, HL Park, AL Carvalho, M Osada, ... Cancer research 66 (7), 3409-3418, 2006 | 117 | 2006 |
| A p53-type response element in the GDF15 promoter confers high specificity for p53 activation M Osada, HL Park, MJ Park, JW Liu, G Wu, B Trink, D Sidransky Biochemical and biophysical research communications 354 (4), 913-918, 2007 | 93 | 2007 |
| PGP9. 5 methylation in diffuse-type gastric cancer K Yamashita, HL Park, MS Kim, M Osada, Y Tokumaru, H Inoue, M Mori, ... Cancer Research 66 (7), 3921-3927, 2006 | 92 | 2006 |
| Pharmacologic unmasking of epigenetically silenced genes in breast cancer KL Ostrow, HL Park, MO Hoque, MS Kim, J Liu, P Argani, W Westra, ... Clinical Cancer Research 15 (4), 1184-1191, 2009 | 87 | 2009 |
| Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma AL Carvalho, A Chuang, WW Jiang, J Lee, S Begum, L Poeta, M Zhao, ... Cancer research 66 (19), 9401-9407, 2006 | 84 | 2006 |
| The role of PGP9. 5 as a tumor suppressor gene in human cancer Y Tokumaru, K Yamashita, MS Kim, HL Park, M Osada, M Mori, ... International journal of cancer 123 (4), 753-759, 2008 | 78 | 2008 |
| Altered sumoylation of p63α contributes to the split-hand/foot malformation phenotype YP Huang, G Wu, Z Guo, M Osada, T Fomenkov, HL Park, B Trink, ... Cell cycle 3 (12), 1587-1596, 2004 | 77 | 2004 |
| Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the women’s health initiative DR Parker, B Lu, M Sands-Lincoln, CH Kroenke, CC Lee, M O’Sullivan, ... The Annals of Family Medicine 12 (4), 302-309, 2014 | 74 | 2014 |
| Quantitative hypermethylation of NMDAR2B in human gastric cancer JW Liu, MS Kim, J Nagpal, K Yamashita, L Poeta, X Chang, J Lee, ... International journal of cancer 121 (9), 1994-2000, 2007 | 68 | 2007 |
| HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma K Yamashita, MS Kim, HL Park, Y Tokumaru, M Osada, H Inoue, M Mori, ... Molecular Cancer Research 6 (1), 31-41, 2008 | 59 | 2008 |
